125 related articles for article (PubMed ID: 28956604)
1. Disease Association and Druggability of WD40 Repeat Proteins.
Song R; Wang ZD; Schapira M
J Proteome Res; 2017 Oct; 16(10):3766-3773. PubMed ID: 28956604
[TBL] [Abstract][Full Text] [Related]
2. WD40 repeat domain proteins: a novel target class?
Schapira M; Tyers M; Torrent M; Arrowsmith CH
Nat Rev Drug Discov; 2017 Nov; 16(11):773-786. PubMed ID: 29026209
[TBL] [Abstract][Full Text] [Related]
3. WD40-Repeat Proteins in Ciliopathies and Congenital Disorders of Endocrine System.
Kim Y; Kim SH
Endocrinol Metab (Seoul); 2020 Sep; 35(3):494-506. PubMed ID: 32894826
[TBL] [Abstract][Full Text] [Related]
4. The role of WDR76 protein in human diseases.
Yang J; Wang F; Chen B
Bosn J Basic Med Sci; 2021 Oct; 21(5):528-534. PubMed ID: 33714259
[TBL] [Abstract][Full Text] [Related]
5. The WD40-repeat protein WDR-48 promotes the stability of the deubiquitinating enzyme USP-46 by inhibiting its ubiquitination and degradation.
Hodul M; Ganji R; Dahlberg CL; Raman M; Juo P
J Biol Chem; 2020 Aug; 295(33):11776-11788. PubMed ID: 32587090
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.
Dayebgadoh G; Sardiu ME; Florens L; Washburn MP
J Proteome Res; 2019 Sep; 18(9):3479-3491. PubMed ID: 31353912
[TBL] [Abstract][Full Text] [Related]
7. WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy.
Kannan M; Bayam E; Wagner C; Rinaldi B; Kretz PF; Tilly P; Roos M; McGillewie L; Bär S; Minocha S; Chevalier C; Po C; ; Chelly J; Mandel JL; Borgatti R; Piton A; Kinnear C; Loos B; Adams DJ; Hérault Y; Collins SC; Friant S; Godin JD; Yalcin B
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9308-E9317. PubMed ID: 29078390
[TBL] [Abstract][Full Text] [Related]
8. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
[No Abstract] [Full Text] [Related]
9. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG
IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
[TBL] [Abstract][Full Text] [Related]
10. Variants in the WDR44 WD40-repeat domain cause a spectrum of ciliopathy by impairing ciliogenesis initiation.
Accogli A; Shakya S; Yang T; Insinna C; Kim SY; Bell D; Butov KR; Severino M; Niceta M; Scala M; Lee HS; Yoo T; Stauffer J; Zhao H; Fiorillo C; Pedemonte M; Diana MC; Baldassari S; Zakharova V; Shcherbina A; Rodina Y; Fagerberg C; Roos LS; Wierzba J; Dobosz A; Gerard A; Potocki L; Rosenfeld JA; Lalani SR; Scott TM; Scott D; Azamian MS; Louie R; Moore HW; Champaigne NL; Hollingsworth G; Torella A; Nigro V; Ploski R; Salpietro V; Zara F; Pizzi S; Chillemi G; Ognibene M; Cooney E; Do J; Linnemann A; Larsen MJ; Specht S; Walters KJ; Choi HJ; Choi M; Tartaglia M; Youkharibache P; Chae JH; Capra V; Park SG; Westlake CJ
Nat Commun; 2024 Jan; 15(1):365. PubMed ID: 38191484
[TBL] [Abstract][Full Text] [Related]
11. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
Daks AA; Melino D; Barlev NA
Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery and assay development in the ubiquitin-proteasome system.
Berkers CR; Ovaa H
Biochem Soc Trans; 2010 Feb; 38(Pt 1):14-20. PubMed ID: 20074028
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in the discovery of epigenetic inhibitors for the treatment of cancer.
Verma SK
Methods Mol Biol; 2015; 1238():677-88. PubMed ID: 25421686
[TBL] [Abstract][Full Text] [Related]
15. [Proteasome oncology: pioneer a new field in drug development].
Mita N; Murata S
Nihon Rinsho; 2012 Apr; 70 Suppl 2():96-102. PubMed ID: 23133935
[No Abstract] [Full Text] [Related]
16. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
Mooneyham A; Bazzaro M
Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
[TBL] [Abstract][Full Text] [Related]
17. Identification of WD40 repeats by secondary structure-aided profile-profile alignment.
Wang C; Dong X; Han L; Su XD; Zhang Z; Li J; Song J
J Theor Biol; 2016 Jun; 398():122-9. PubMed ID: 27021623
[TBL] [Abstract][Full Text] [Related]
18. The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.
He Y; Selvaraju S; Curtin ML; Jakob CG; Zhu H; Comess KM; Shaw B; The J; Lima-Fernandes E; Szewczyk MM; Cheng D; Klinge KL; Li HQ; Pliushchev M; Algire MA; Maag D; Guo J; Dietrich J; Panchal SC; Petros AM; Sweis RF; Torrent M; Bigelow LJ; Senisterra G; Li F; Kennedy S; Wu Q; Osterling DJ; Lindley DJ; Gao W; Galasinski S; Barsyte-Lovejoy D; Vedadi M; Buchanan FG; Arrowsmith CH; Chiang GG; Sun C; Pappano WN
Nat Chem Biol; 2017 Apr; 13(4):389-395. PubMed ID: 28135237
[TBL] [Abstract][Full Text] [Related]
19. Double autoinhibition mechanism of signal transduction ATPases with numerous domains (STAND) with a tetratricopeptide repeat sensor.
Lisa MN; Cvirkaite-Krupovic V; Richet E; André-Leroux G; Alzari PM; Haouz A; Danot O
Nucleic Acids Res; 2019 Apr; 47(7):3795-3810. PubMed ID: 30788511
[TBL] [Abstract][Full Text] [Related]
20. WD40-Repeat Proteins in Plant Cell Wall Formation: Current Evidence and Research Prospects.
Guerriero G; Hausman JF; Ezcurra I
Front Plant Sci; 2015; 6():1112. PubMed ID: 26734023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
